{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:02:56Z","timestamp":1772337776398,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1016\/s0006-291x(03)00124-4","type":"journal-article","created":{"date-parts":[[2003,2,28]],"date-time":"2003-02-28T14:00:13Z","timestamp":1046440813000},"page":"238-245","source":"Crossref","is-referenced-by-count":34,"title":["Merlin suppresses the SRE-dependent transcription by inhibiting the activation of Ras-ERK pathway"],"prefix":"10.1016","volume":"302","author":[{"given":"Jung Yeon","family":"Lim","sequence":"first","affiliation":[]},{"given":"Hongtae","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Young Hoon","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Sae Woong","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Pil-Woo","family":"Huh","sequence":"additional","affiliation":[]},{"given":"Kweon-Haeng","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Sin-Soo","family":"Jeun","sequence":"additional","affiliation":[]},{"given":"Hyoung Kyun","family":"Rha","sequence":"additional","affiliation":[]},{"given":"Joon-ki","family":"Kang","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0006-291X(03)00124-4_BIB1","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.56.12.1766","article-title":"Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2","volume":"56","author":"Gijtenbeek","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S0006-291X(03)00124-4_BIB2","series-title":"The Neurofibromatoses: A Pathogenetic and Clinical Overview","first-page":"414","author":"Short","year":"1994"},{"key":"10.1016\/S0006-291X(03)00124-4_BIB3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jmg.29.12.847","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counseling","volume":"29","author":"Evans","year":"1992","journal-title":"J. Med. Genet."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"72","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0006-291X(03)00124-4_BIB5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/329246a0","article-title":"Genetic linkage analysis of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22","volume":"329","author":"Rouleau","year":"1987","journal-title":"Nature"},{"key":"10.1016\/S0006-291X(03)00124-4_BIB6","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis","volume":"29","author":"Evans","year":"1992","journal-title":"Q. J. Med."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3171\/jns.1999.91.1.0085","article-title":"Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer","volume":"91","author":"Ikeda","year":"1999","journal-title":"J. Neurosurg."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44","volume":"15","author":"Morrison","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB9","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","article-title":"Conditional biallelic NF2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2","volume":"14","author":"Giovannini","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1101\/gad.12.8.1121","article-title":"Mice heterozygous for a mutation at the NF2 tumor suppressor locus develop a range of highly metastatic tumors","volume":"12","author":"McClatchey","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB11","doi-asserted-by":"crossref","first-page":"23387","DOI":"10.1016\/S0021-9258(17)31525-9","article-title":"An anti-ras function of neurofibromatosis type 2 gene product (NF2\/Merlin)","volume":"269","author":"Tikoo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","article-title":"The NF2 tumor suppressor, merlin, functions in rac-dependent signaling","volume":"1","author":"Shaw","year":"2001","journal-title":"Dev. Cell"},{"key":"10.1016\/S0006-291X(03)00124-4_BIB13","doi-asserted-by":"crossref","first-page":"22033","DOI":"10.1074\/jbc.274.31.22033","article-title":"Multiple ras effector pathways contribute to G1 cell cycle progression","volume":"274","author":"Gille","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB14","doi-asserted-by":"crossref","first-page":"38449","DOI":"10.1074\/jbc.M102165200","article-title":"ERK2-and p90RSK2-dependent pathways regulate the CCAAT\/enhancer\u2013binding protein-\u03b2 interaction with serum response factor","volume":"276","author":"Hanlon","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(92)90194-H","article-title":"Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element","volume":"68","author":"Dalton","year":"1992","journal-title":"Cell"},{"key":"10.1016\/S0006-291X(03)00124-4_BIB16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.7618106","article-title":"Integration of MAP kinase signal transduction pathways at the serum response element","volume":"269","author":"Whitmarsh","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0006-291X(03)00124-4_BIB17","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/emboj\/17.6.1740","article-title":"Differential targeting of MAP kinas to the ETS-domain transcription factor Elk-1","volume":"17","author":"Yang","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB18","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1074\/jbc.M006678200","article-title":"Opposing roles of Elk-1 and its brain-specific isoform, short Elk-1, in nerve growth factor-induced PC12 differentiation","volume":"276","author":"Vanhoutte","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0959-437X(94)90097-3","article-title":"Ternary complex factors: growth factor regulated transcriptional activators","volume":"4","author":"Treisman","year":"1994","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB20","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1002\/j.1460-2075.1995.tb00284.x","article-title":"Induction of c-fos expression through JNK-mediated TCF\/Elk-1 phosphorylation","volume":"14","author":"Cavigelli","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB21","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1002\/j.1460-2075.1996.tb01046.x","article-title":"The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light","volume":"15","author":"Price","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0959-437X(05)80277-1","article-title":"The SRF and MCM1 transcription factors","volume":"2","author":"Treisman","year":"1992","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s001090050063","article-title":"Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways","volume":"74","author":"Whitmarsh","year":"1996","journal-title":"J. Mol. Med."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0006-291X(02)02077-6","article-title":"Inhibition of NF-\u03baB activation by merlin","volume":"296","author":"Kim","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB25","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1093\/nar\/17.15.6420","article-title":"Rapid test for in vivo stability and DNA binding of mutated octamer binding proteins with \u2018mini-extracts\u2019 prepared from transfected cells","volume":"17","author":"Muller","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB27","first-page":"597","article-title":"The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain","volume":"68","author":"Marais","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0006-291X(03)00124-4_BIB28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0955-0674(96)80067-6","article-title":"Regulation of transcription by MAP kinase cascades","volume":"8","author":"Treisman","year":"1996","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB29","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/MCB.11.9.4545","article-title":"The serum response factor is extensively modified by phosphorylation following its synthesis in serum-stimulated fibroblasts","volume":"11","author":"Misra","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/j.1460-2075.1992.tb05032.x","article-title":"Casein kinase II phosphorylation increase the rate of serum response factor-binding site exchange","volume":"11","author":"Marais","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB31","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/MCB.13.10.6260","article-title":"A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity","volume":"13","author":"Rivera","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB32","doi-asserted-by":"crossref","first-page":"25951","DOI":"10.1074\/jbc.272.41.25951","article-title":"Growth hormone regulates ternary complex factors and serum response factor associated with the c-fos serum response element","volume":"272","author":"Liao","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0006-291X(03)00124-4_BIB33","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product","volume":"15","author":"Sherman","year":"1997","journal-title":"Oncogene"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X03001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X03001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T21:10:35Z","timestamp":1682457035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X03001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0006291X03001244"],"URL":"https:\/\/doi.org\/10.1016\/s0006-291x(03)00124-4","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}